Lista de obras -

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

article

Acute Cardiorenal Syndrome in Heart Failure: from Dogmas to Advances

scientific article published on 10 September 2020

Acute decompensated heart failure: update on new and emerging evidence and directions for future research

artículo científico publicado en 2013

Aldosterone-Receptor Antagonists in Heart Failure: Insights After EMPHASIS-HF ⬇️

artículo científico publicado el 1 de marzo de 2011

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

artículo científico publicado en 2019

Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysis

artículo científico publicado en 2021

Cardiorenal Syndrome: Diagnosis, Treatment, and Clinical Outcomes ⬇️

artículo científico publicado el 1 de diciembre de 2010

Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study

artículo científico publicado en 2012

Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial

artículo científico publicado en 2018

Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

artículo científico publicado en 2015

Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial

artículo científico publicado en 2014

Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data

artículo científico publicado en 2013

Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward

artículo científico publicado en 2012

Device monitoring strategies in acute heart failure syndromes ⬇️

artículo científico publicado el 1 de septiembre de 2011

Diminished Antioxidant Activity of High-Density Lipoprotein–Associated Proteins in Systolic Heart Failure ⬇️

artículo científico publicado el 9 de noviembre de 2010

Diuretic response in acute heart failure-an analysis from ASCEND-HF.

artículo científico publicado en 2015

Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

scientific article published on 17 September 2020

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial

artículo científico

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study

artículo científico publicado en 2015

Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial

artículo científico publicado en 2017

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure ⬇️

artículo científico publicado el 16 de abril de 2003

Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia

artículo científico publicado en 2013

Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project

artículo científico publicado en 2011

High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial.

artículo científico publicado en 2014

Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF

artículo científico publicado en 2014

Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities ⬇️

artículo científico publicado el 21 de enero de 2011

Implications of renin-angiotensin-system blocker discontinuation in acute decompensated heart failure with systolic dysfunction

scientific article published on 09 September 2019

Improved Prediction of Cardiovascular Disease Based on a Panel of Single Nucleotide Polymorphisms Identified Through Genome-Wide Association Studies ⬇️

artículo científico publicado el 21 de agosto de 2010

Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy

artículo científico publicado en 2015

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee

artículo científico publicado en 2012

Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial

artículo científico publicado en 2016

Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure.

artículo científico publicado en 2015

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.

artículo científico publicado en 2018

Ivabradine in heart failure: to SHIFT or not to SHIFT ⬇️

artículo científico publicado el 1 de marzo de 2011

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

artículo científico publicado en 2011

Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.

artículo científico publicado en 2015

Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.

artículo científico publicado en 2015

Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial

artículo científico publicado en 2013

Microbe-derived uremic solutes enhance thrombosis potential in the host

artículo científico publicado en 2023

Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).

artículo científico publicado en 2014

New gene functions in megakaryopoiesis and platelet formation

artículo científico publicado en 2011

Novel pharmacological treatments for heart failure ⬇️

artículo científico publicado el 1 de noviembre de 2003

Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial

artículo científico publicado en 2004

Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab

artículo científico publicado en 2002

Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease ⬇️

artículo científico publicado el 8 de noviembre de 2010

Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models

artículo científico

Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF

scientific article published on 4 April 2019

Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure

artículo científico publicado en 2015

Protecting the heart in cancer therapy

artículo científico publicado en 2018

Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function

artículo científico publicado en 2022

Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure

artículo científico publicado en 2016

Recent Advances in Understanding and Managing Cardiomyopathy.

artículo científico publicado en 2017

Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)

scientific article published on 03 August 2018

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

artículo científico publicado en 2017

Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study

artículo científico publicado en 2010

Seventy-five genetic loci influencing the human red blood cell

artículo científico publicado en 2012

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

artículo científico publicado en 2019

The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF

artículo científico publicado en 2015

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome ⬇️

artículo científico publicado el 1 de junio de 2008

Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)

artículo científico publicado en 2016

Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

artículo científico publicado en 2012

Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

artículo científico publicado en 2012

Worsening Renal Function in Acute Heart Failure Patients Undergoing Aggressive Diuresis is Not Associated with Tubular Injury

artículo científico publicado en 2018

Lista de obras de

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

Acute Cardiorenal Syndrome in Heart Failure: from Dogmas to Advances

Acute decompensated heart failure: update on new and emerging evidence and directions for future research

Aldosterone-Receptor Antagonists in Heart Failure: Insights After EMPHASIS-HF ⬇️

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysis

Cardiorenal Syndrome: Diagnosis, Treatment, and Clinical Outcomes ⬇️

Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study

Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial

Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial

Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data

Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward

Device monitoring strategies in acute heart failure syndromes ⬇️

Diminished Antioxidant Activity of High-Density Lipoprotein–Associated Proteins in Systolic Heart Failure ⬇️

Diuretic response in acute heart failure-an analysis from ASCEND-HF.

Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study

Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure ⬇️

Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia

Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project

High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial.

Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF

Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities ⬇️

Implications of renin-angiotensin-system blocker discontinuation in acute decompensated heart failure with systolic dysfunction

Improved Prediction of Cardiovascular Disease Based on a Panel of Single Nucleotide Polymorphisms Identified Through Genome-Wide Association Studies ⬇️

Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee

Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial

Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure.

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.

Ivabradine in heart failure: to SHIFT or not to SHIFT ⬇️

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.

Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.

Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial

Microbe-derived uremic solutes enhance thrombosis potential in the host

Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).

New gene functions in megakaryopoiesis and platelet formation

Novel pharmacological treatments for heart failure ⬇️

Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial

Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab

Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease ⬇️

Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models

Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF

Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure

Protecting the heart in cancer therapy

Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function

Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure

Recent Advances in Understanding and Managing Cardiomyopathy.

Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study

Seventy-five genetic loci influencing the human red blood cell

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome ⬇️

Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)

Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

Worsening Renal Function in Acute Heart Failure Patients Undergoing Aggressive Diuresis is Not Associated with Tubular Injury